Publisher Correction: Programmed death ligand 1 signals in cancer cells (Nature Reviews Cancer, (2022), 22, 3, (174-189), 10.1038/s41568-021-00431-4)

Anand V.R. Kornepati, Ratna K. Vadlamudi, Tyler J. Curiel

Research output: Contribution to journalComment/debatepeer-review

Abstract

This article was originally published with the title ‘Programmed cell death 1 ligand 1 signals in cancer cells’. This has been corrected in the HTML and PDF versions of the article to reflect the more common usage of the definition of PDL1 as ‘programmed death ligand 1’. In addition, the definitions for the acronyms PD1 (programmed death 1) and PDL1 have been added to the abstract, the introduction and display items of the article.

Original languageEnglish (US)
Pages (from-to)190
Number of pages1
JournalNature Reviews Cancer
Volume22
Issue number3
DOIs
StatePublished - Mar 2022

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Publisher Correction: Programmed death ligand 1 signals in cancer cells (Nature Reviews Cancer, (2022), 22, 3, (174-189), 10.1038/s41568-021-00431-4)'. Together they form a unique fingerprint.

Cite this